GHANA-HEALTH-VACCINATION-MALARIA

A nurse shows the Malaria vaccine Mosquirix at the Ewin Polyclinic in Cape Coast, Ghana, on April 30, 2019. Ewim Polyclinic on April 30, 2019 was the first in Ghana to roll out the Malaria vaccine Mosquirix. After Malawi, Ghana is the second country to launch the vaccine. Known by its lab initials as RTS,S but branded Mosquirix, the vaccine has passed lengthy scientific trials, which found it to be safe and reduced the risk of Malaria by nearly 40 percent -- the best-ever recorded. It was approved by European regulators in 2015. (Photo by CRISTINA ALDEHUELA / AFP) (Photo by CRISTINA ALDEHUELA/AFP via Getty Images)
A nurse shows the Malaria vaccine Mosquirix at the Ewin Polyclinic in Cape Coast, Ghana, on April 30, 2019. Ewim Polyclinic on April 30, 2019 was the first in Ghana to roll out the Malaria vaccine Mosquirix. After Malawi, Ghana is the second country to launch the vaccine. Known by its lab initials as RTS,S but branded Mosquirix, the vaccine has passed lengthy scientific trials, which found it to be safe and reduced the risk of Malaria by nearly 40 percent -- the best-ever recorded. It was approved by European regulators in 2015. (Photo by CRISTINA ALDEHUELA / AFP) (Photo by CRISTINA ALDEHUELA/AFP via Getty Images)
GHANA-HEALTH-VACCINATION-MALARIA
PURCHASE A LICENSE
How can I use this image?
€475.00
EUR

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.TO GO WITH AFP STORY Stacey KNOTT
Credit:
CRISTINA ALDEHUELA / Contributor
Editorial #:
1140249225
Collection:
AFP
Date created:
April 30, 2019
License type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
AFP_1G20IZ
Max file size:
3600 x 2400 px (12.00 x 8.00 in) - 300 dpi - 3 MB